Growing rates of chronic diseases is expected to drive the U.S home infusion therapy market. The U.S. home infusion therapy market is estimated to reach a market value of US$ 8,672.3 million in 2019 and it is expected to reach US$ 19,250.0 million by 2027, growing at an estimated CAGR of 10.5% over the forecast period.
The need to provide continuous care to elderly population and chronic disease patients at remote locations generates demand for various infusion therapy devices and solutions. Increasing incidences of respiratory disorders, cardiovascular diseases and other chronic ailments will result in more and more adoption of infusion products, which will thus propel the U.S. home infusion therapy market growth. Industry growth is also attributed to rising average household income across the nation and to availability of home healthcare providers. A large proportion of retired elderly population has monetary reserve to avail healthcare at their homes. In spite of many market growth favoring parameters, factors such as sporadic affordability, limitations on reimbursement and insurance restrains market expansion across the U.S. A considerable stratum of geriatric population experience home infusion therapy shortfall due to scarcity in number of home healthcare agencies in remote areas of certain states.
The detailed research study provides qualitative and quantitative analysis of U.S. home infusion therapy market. The market has been analyzed from the scope of demand as well as supply. The analysis of demand covers market revenue across regions and further also across all the major countries. The analysis of supply covers the major market players and their regional and global presence and strategies. The geographical analysis emphasizes on each of the major countries across North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
U.S. Home Infusion Therapy Market (US$ Million) 2018, By Product
Key Findings of the Report: